DE69625699D1 - Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung - Google Patents

Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung

Info

Publication number
DE69625699D1
DE69625699D1 DE69625699T DE69625699T DE69625699D1 DE 69625699 D1 DE69625699 D1 DE 69625699D1 DE 69625699 T DE69625699 T DE 69625699T DE 69625699 T DE69625699 T DE 69625699T DE 69625699 D1 DE69625699 D1 DE 69625699D1
Authority
DE
Germany
Prior art keywords
acid salt
producing
same
salt compounds
aminic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625699T
Other languages
English (en)
Other versions
DE69625699T2 (de
Inventor
Seo Hong Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69625699D1 publication Critical patent/DE69625699D1/de
Application granted granted Critical
Publication of DE69625699T2 publication Critical patent/DE69625699T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
DE69625699T 1995-08-16 1996-08-16 Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung Expired - Lifetime DE69625699T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/515,790 US5686588A (en) 1995-08-16 1995-08-16 Amine acid salt compounds and process for the production thereof
PCT/US1996/013246 WO1997007112A1 (en) 1995-08-16 1996-08-16 Amine acid salt compounds and process for the production thereof

Publications (2)

Publication Number Publication Date
DE69625699D1 true DE69625699D1 (de) 2003-02-13
DE69625699T2 DE69625699T2 (de) 2003-11-06

Family

ID=24052741

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625699T Expired - Lifetime DE69625699T2 (de) 1995-08-16 1996-08-16 Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung

Country Status (13)

Country Link
US (1) US5686588A (de)
EP (1) EP0859768B1 (de)
JP (1) JPH11508601A (de)
KR (1) KR100259205B1 (de)
CN (1) CN100338050C (de)
AT (1) ATE230737T1 (de)
AU (1) AU713507B2 (de)
BR (1) BR9610288A (de)
CA (1) CA2227264C (de)
DE (1) DE69625699T2 (de)
IL (1) IL123212A0 (de)
MX (1) MX9801205A (de)
WO (1) WO1997007112A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
JP4790123B2 (ja) 1998-07-24 2011-10-12 ヨー、セオ、ホン 胆汁酸を有する透明水溶液型製剤の調剤
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
JP2004500378A (ja) * 2000-02-04 2004-01-08 ヨー、セオ、ホン 胆汁酸を含有する清浄水溶液製型の製造
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
US8173627B2 (en) * 2004-08-30 2012-05-08 Seo Hong Yoo Neuroprotective effect of solubilized UDCA in focal ischemic model
ATE506955T1 (de) * 2004-10-15 2011-05-15 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
AU2005302452B2 (en) * 2004-11-01 2010-12-09 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in Amyotrophic Lateral Sclerosis
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
WO2006109324A2 (en) * 2005-04-13 2006-10-19 Lupin Limited Processes for preparation of amorphous cefepime acid addition salts
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107424A (en) * 1972-10-06 1978-08-15 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai 1-N-[(S)-α-hydroxy-ω-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CA1171096A (en) * 1980-01-08 1984-07-17 Glaxo Group Limited Process for the preparation of a furan derivative
JPS56103171A (en) * 1980-01-08 1981-08-18 Glaxo Group Ltd Manufacture of furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
ES509777A0 (es) * 1981-02-20 1983-02-01 Glaxo Group Ltd Un procedimiento para la preparacion de ranitidina.
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
GB8415254D0 (en) * 1984-06-15 1984-07-18 Glaxo Group Ltd Amine derivatives
GB8907700D0 (en) * 1989-04-05 1989-05-17 Fine Organics Ltd Preparation of substituted ethenes
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
AU6725596A (en) 1997-03-12
EP0859768A1 (de) 1998-08-26
EP0859768B1 (de) 2003-01-08
DE69625699T2 (de) 2003-11-06
MX9801205A (es) 1998-04-30
CA2227264A1 (en) 1997-02-27
IL123212A0 (en) 1998-09-24
CN100338050C (zh) 2007-09-19
CA2227264C (en) 2002-10-22
JPH11508601A (ja) 1999-07-27
KR100259205B1 (ko) 2000-07-01
EP0859768A4 (de) 1998-11-11
WO1997007112A1 (en) 1997-02-27
CN1198744A (zh) 1998-11-11
BR9610288A (pt) 1999-07-27
US5686588A (en) 1997-11-11
KR19990037637A (ko) 1999-05-25
AU713507B2 (en) 1999-12-02
ATE230737T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
DE69625699D1 (de) Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung
ES8801210A1 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
PL266567A1 (en) A method of crystalline acid hydrates 7-2-/2-aminotiazolil-4/4-carboxylobutene-2-oiloamino-3-cefemocarboxyl-4 production
ATE200479T1 (de) Stabile nichthygroskopische salze von l(- )carnitin und alkanoyl-l(-)carnitinen, verfahren zu ihrer herstellung und feste, oral verabreichbare zusammensetzungen,die sie enthalten
ATE242241T1 (de) Imidazopyridinderivate und verfahren zu ihrer herstellung
CA2080221A1 (en) An improved process for the preparation of substituted indolone derivatives
CA2216633A1 (en) Synthesis of bis-indolylmaleimides
DE3578687D1 (de) N-substituierte neuraminsaeure-derivate und verfahren zu ihrer herstellung.
ATE107920T1 (de) Verfahren zur herstellung einer chinolincarbonsäure.
HUT45518A (en) Process for producing 1,5-benzothiazepine derivatives and pharmaceutics comprising these compounds
DE58900098D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE41154T1 (de) Verfahren zur herstellung alkanphosphoniger saeuren.
DE69917615D1 (de) Ein verfahren zur herstellung von (2s,2'r,3'r)-2-(2,3-dicarboxycyclopropyl)-glycin
ATE457300T1 (de) Dikarbonsäuresalze des acetyl-l-carnitins und verfahren zu ihrer herstellung
CA2282381A1 (en) Process for the preparation of nicotinic acids
AU2150288A (en) Method of forming crystalline compound semiconductor film
KR860004838A (ko) 결정상태의 글루타민산을 제조하는 방법
ES8601099A1 (es) Procedimiento para la preparacion de nuevos derivados de n-(metoxifenacil)-amina
CA2145181A1 (en) Process for preparing 1-2,-substituted-5-formylimidazoles
AT400030B (de) Verfahren zur herstellung von 1-alkylamino-2-nitroethen-1-thiolderivaten
MY110724A (en) Process for converting loracarbef dihydrate to loracarbef monohydrate
CA2277151A1 (en) Synthesis of acyclic nucleoside derivatives
HUT46701A (en) Process for producing alpha-amino-alkyl-phosphonic acids
TH44062EX (th) กรรมวิธีสำหรับเปลี่ยนโลราคาร์เบฟ ไดไฮเดรท ไปเป็น โลราคาร์เบฟ มอนอไฮเดรท
DE3679783D1 (de) Verfahren zur herstellung von beta-lactamderivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition